FDA Drug Application (020611) for DOVONEX by LEO PHARM

Back to FDA Applications sponsored by LEO PHARM

Application Number020611
Product Number001
FormSOLUTION;TOPICAL
Dosage0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDOVONEX
Active IngredientCALCIPOTRIENE

Active IngredientCount
List of drugs with Active Ingredient CALCIPOTRIENE4


Back to FDA Applications sponsored by LEO PHARM